Are clinics missing advanced HIV cases? a new study investigates
NCT ID NCT07760324
First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time
Summary
This study looks at how often CD4 cell counts are measured when adults in Zambia begin or restart antiretroviral therapy (ART) after a long break. The goal is to see how many people have advanced HIV disease and whether low testing rates prevent proper care. Researchers will assess participants' health stage, CD4 count, and treatment history, along with barriers to testing and care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could improve how clinics identify and manage people with advanced HIV, potentially reducing complications and deaths.
- What could go wrong
- This is an observational study, so it won't test a new treatment. Findings may not apply beyond the specific clinics and population studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV (HUMAN IMMUNODEFICIENCY VIRUS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chawama
Lusaka, Lusaka Province, 10101, Zambia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cash for care: a simple incentive to keep HIV patients on track
- Olive oil as a shield? trial tests whether a daily spoonful cuts heart risks in HIV
- Specialized HIV clinics: a new strategy to beat the virus?
- A mobile x-ray van with AI could spot TB before it spreads
- A simple survey may curb teen drinking and HIV risk — a trial puts it to the test
- HIV and cancer: study seeks to uncover hidden risk factors